nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT1A1—hematologic cancer	0.251	0.81	CbGaD
Morphine—ABCB1—hematologic cancer	0.0587	0.19	CbGaD
Morphine—UGT1A1—Nilotinib—hematologic cancer	0.0279	0.0734	CbGbCtD
Morphine—UGT2B7—Epirubicin—hematologic cancer	0.0228	0.06	CbGbCtD
Morphine—UGT1A1—Irinotecan—hematologic cancer	0.0192	0.0504	CbGbCtD
Morphine—UGT1A1—Etoposide—hematologic cancer	0.0153	0.0404	CbGbCtD
Morphine—ABCB1—Lenalidomide—hematologic cancer	0.0135	0.0357	CbGbCtD
Morphine—CYP2C8—Bortezomib—hematologic cancer	0.0123	0.0323	CbGbCtD
Morphine—CYP2D6—Lomustine—hematologic cancer	0.0119	0.0312	CbGbCtD
Morphine—CYP2D6—Idarubicin—hematologic cancer	0.0106	0.0278	CbGbCtD
Morphine—CYP2C8—Ifosfamide—hematologic cancer	0.00941	0.0248	CbGbCtD
Morphine—CYP2D6—Hydroxyurea—hematologic cancer	0.00899	0.0237	CbGbCtD
Morphine—CYP2C8—Nilotinib—hematologic cancer	0.00817	0.0215	CbGbCtD
Morphine—CYP3A4—Bexarotene—hematologic cancer	0.00812	0.0214	CbGbCtD
Morphine—ABCB1—Daunorubicin—hematologic cancer	0.00794	0.0209	CbGbCtD
Morphine—CYP2D6—Bortezomib—hematologic cancer	0.00782	0.0206	CbGbCtD
Morphine—ABCB1—Alitretinoin—hematologic cancer	0.00778	0.0205	CbGbCtD
Morphine—CYP3A4—Lomustine—hematologic cancer	0.00755	0.0199	CbGbCtD
Morphine—CYP3A4—Busulfan—hematologic cancer	0.00755	0.0199	CbGbCtD
Morphine—CYP3A4—Thiotepa—hematologic cancer	0.00673	0.0177	CbGbCtD
Morphine—ABCB1—Imatinib—hematologic cancer	0.00608	0.016	CbGbCtD
Morphine—CYP2D6—Imatinib—hematologic cancer	0.00573	0.0151	CbGbCtD
Morphine—ABCB1—Nilotinib—hematologic cancer	0.00553	0.0145	CbGbCtD
Morphine—ABCB1—Vinorelbine—hematologic cancer	0.00548	0.0144	CbGbCtD
Morphine—CYP3A4—Methoxsalen—hematologic cancer	0.00523	0.0138	CbGbCtD
Morphine—CYP2D6—Nilotinib—hematologic cancer	0.00521	0.0137	CbGbCtD
Morphine—CYP2D6—Vinorelbine—hematologic cancer	0.00516	0.0136	CbGbCtD
Morphine—CYP3A4—Bortezomib—hematologic cancer	0.00497	0.0131	CbGbCtD
Morphine—ABCB1—Dasatinib—hematologic cancer	0.00489	0.0129	CbGbCtD
Morphine—ABCB1—Mitoxantrone—hematologic cancer	0.00483	0.0127	CbGbCtD
Morphine—CYP3A4—Daunorubicin—hematologic cancer	0.00476	0.0125	CbGbCtD
Morphine—CYP2C8—Etoposide—hematologic cancer	0.0045	0.0118	CbGbCtD
Morphine—ABCB1—Betamethasone—hematologic cancer	0.0043	0.0113	CbGbCtD
Morphine—ABCB1—Gemcitabine—hematologic cancer	0.00426	0.0112	CbGbCtD
Morphine—ABCB1—Prednisolone—hematologic cancer	0.00424	0.0112	CbGbCtD
Morphine—CYP3A4—Cytarabine—hematologic cancer	0.0042	0.011	CbGbCtD
Morphine—CYP3A4—Teniposide—hematologic cancer	0.00413	0.0109	CbGbCtD
Morphine—ABCB1—Prednisone—hematologic cancer	0.00401	0.0105	CbGbCtD
Morphine—CYP3A4—Ifosfamide—hematologic cancer	0.00382	0.01	CbGbCtD
Morphine—ABCB1—Irinotecan—hematologic cancer	0.0038	0.01	CbGbCtD
Morphine—CYP2C8—Dexamethasone—hematologic cancer	0.0037	0.00973	CbGbCtD
Morphine—CYP3A4—Imatinib—hematologic cancer	0.00364	0.00959	CbGbCtD
Morphine—CYP3A4—Ruxolitinib—hematologic cancer	0.00343	0.00903	CbGbCtD
Morphine—ABCB1—Vinblastine—hematologic cancer	0.00338	0.00889	CbGbCtD
Morphine—ABCB1—Vincristine—hematologic cancer	0.00332	0.00874	CbGbCtD
Morphine—CYP3A4—Nilotinib—hematologic cancer	0.00331	0.00872	CbGbCtD
Morphine—CYP3A4—Vinorelbine—hematologic cancer	0.00328	0.00864	CbGbCtD
Morphine—CYP2D6—Vinblastine—hematologic cancer	0.00318	0.00838	CbGbCtD
Morphine—ABCB1—Cisplatin—hematologic cancer	0.0031	0.00815	CbGbCtD
Morphine—ABCB1—Etoposide—hematologic cancer	0.00304	0.00801	CbGbCtD
Morphine—CYP3A4—Triamcinolone—hematologic cancer	0.003	0.00791	CbGbCtD
Morphine—CYP3A4—Dasatinib—hematologic cancer	0.00293	0.0077	CbGbCtD
Morphine—CYP3A4—Mitoxantrone—hematologic cancer	0.00289	0.00761	CbGbCtD
Morphine—CYP3A4—Betamethasone—hematologic cancer	0.00258	0.00678	CbGbCtD
Morphine—CYP3A4—Prednisolone—hematologic cancer	0.00254	0.00669	CbGbCtD
Morphine—ABCB1—Dexamethasone—hematologic cancer	0.0025	0.00659	CbGbCtD
Morphine—CYP3A4—Prednisone—hematologic cancer	0.0024	0.00632	CbGbCtD
Morphine—CYP2D6—Dexamethasone—hematologic cancer	0.00236	0.00621	CbGbCtD
Morphine—CYP3A4—Irinotecan—hematologic cancer	0.00228	0.00599	CbGbCtD
Morphine—OPRL1—hematopoietic system—hematologic cancer	0.00219	0.155	CbGeAlD
Morphine—ABCB1—Doxorubicin—hematologic cancer	0.00208	0.00546	CbGbCtD
Morphine—CYP3A4—Vinblastine—hematologic cancer	0.00202	0.00533	CbGbCtD
Morphine—ABCB1—Methotrexate—hematologic cancer	0.00201	0.00529	CbGbCtD
Morphine—CYP3A4—Vincristine—hematologic cancer	0.00199	0.00524	CbGbCtD
Morphine—CYP2D6—Doxorubicin—hematologic cancer	0.00196	0.00515	CbGbCtD
Morphine—CYP3A4—Etoposide—hematologic cancer	0.00182	0.0048	CbGbCtD
Morphine—CYP3A4—Dexamethasone—hematologic cancer	0.0015	0.00395	CbGbCtD
Morphine—OPRL1—blood—hematologic cancer	0.00145	0.103	CbGeAlD
Morphine—CYP3A4—Doxorubicin—hematologic cancer	0.00124	0.00327	CbGbCtD
Morphine—UGT2B4—lung—hematologic cancer	0.00121	0.0859	CbGeAlD
Morphine—OPRL1—testis—hematologic cancer	0.0012	0.0849	CbGeAlD
Morphine—Naloxone—CREB1—hematologic cancer	0.00103	0.443	CrCbGaD
Morphine—UGT1A1—hematopoietic system—hematologic cancer	0.000979	0.0692	CbGeAlD
Morphine—OPRL1—lymph node—hematologic cancer	0.000871	0.0616	CbGeAlD
Morphine—OPRM1—hematopoietic system—hematologic cancer	0.00077	0.0545	CbGeAlD
Morphine—UGT1A1—blood—hematologic cancer	0.000649	0.0459	CbGeAlD
Morphine—UGT2B7—testis—hematologic cancer	0.000631	0.0446	CbGeAlD
Morphine—OPRM1—blood—hematologic cancer	0.00051	0.0361	CbGeAlD
Morphine—Naltrexone—UGT1A1—hematologic cancer	0.000496	0.214	CrCbGaD
Morphine—CYP2C8—hematopoietic system—hematologic cancer	0.000463	0.0328	CbGeAlD
Morphine—OPRM1—testis—hematologic cancer	0.000422	0.0298	CbGeAlD
Morphine—CYP3A4—hematopoietic system—hematologic cancer	0.000314	0.0222	CbGeAlD
Morphine—CYP2D6—hematopoietic system—hematologic cancer	0.000309	0.0218	CbGeAlD
Morphine—CYP2C8—blood—hematologic cancer	0.000307	0.0217	CbGeAlD
Morphine—Codeine—SLC22A1—hematologic cancer	0.000304	0.131	CrCbGaD
Morphine—CYP2C8—testis—hematologic cancer	0.000254	0.018	CbGeAlD
Morphine—ABCB1—hematopoietic system—hematologic cancer	0.000222	0.0157	CbGeAlD
Morphine—CYP3A4—blood—hematologic cancer	0.000208	0.0147	CbGeAlD
Morphine—CYP2D6—blood—hematologic cancer	0.000205	0.0145	CbGeAlD
Morphine—Naloxone—ESR1—hematologic cancer	0.000199	0.0861	CrCbGaD
Morphine—CYP2D6—testis—hematologic cancer	0.000169	0.012	CbGeAlD
Morphine—ABCB1—gonad—hematologic cancer	0.000169	0.0119	CbGeAlD
Morphine—ABCB1—blood—hematologic cancer	0.000147	0.0104	CbGeAlD
Morphine—ABCB1—bone marrow—hematologic cancer	0.000142	0.0101	CbGeAlD
Morphine—ABCB1—lung—hematologic cancer	0.000129	0.00912	CbGeAlD
Morphine—ABCB1—testis—hematologic cancer	0.000122	0.00861	CbGeAlD
Morphine—Naltrexone—ABCB1—hematologic cancer	0.000116	0.0502	CrCbGaD
Morphine—Naloxone—ALB—hematologic cancer	8.87e-05	0.0383	CrCbGaD
Morphine—ABCB1—lymph node—hematologic cancer	8.82e-05	0.00624	CbGeAlD
Morphine—Naloxone—ABCB1—hematologic cancer	8.47e-05	0.0366	CrCbGaD
Morphine—Eye disorder—Doxorubicin—hematologic cancer	1.38e-05	6.61e-05	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—hematologic cancer	1.38e-05	6.6e-05	CcSEcCtD
Morphine—Anaemia—Methotrexate—hematologic cancer	1.37e-05	6.57e-05	CcSEcCtD
Morphine—Feeling abnormal—Dexamethasone—hematologic cancer	1.37e-05	6.57e-05	CcSEcCtD
Morphine—Feeling abnormal—Betamethasone—hematologic cancer	1.37e-05	6.57e-05	CcSEcCtD
Morphine—Flushing—Doxorubicin—hematologic cancer	1.37e-05	6.56e-05	CcSEcCtD
Morphine—Flatulence—Epirubicin—hematologic cancer	1.37e-05	6.56e-05	CcSEcCtD
Morphine—Tension—Epirubicin—hematologic cancer	1.36e-05	6.53e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.36e-05	6.52e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.36e-05	6.52e-05	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—hematologic cancer	1.36e-05	6.52e-05	CcSEcCtD
Morphine—Hypersensitivity—Triamcinolone—hematologic cancer	1.35e-05	6.47e-05	CcSEcCtD
Morphine—Nervousness—Epirubicin—hematologic cancer	1.35e-05	6.46e-05	CcSEcCtD
Morphine—Back pain—Epirubicin—hematologic cancer	1.34e-05	6.44e-05	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—hematologic cancer	1.34e-05	6.42e-05	CcSEcCtD
Morphine—Malaise—Methotrexate—hematologic cancer	1.34e-05	6.41e-05	CcSEcCtD
Morphine—Dizziness—Etoposide—hematologic cancer	1.34e-05	6.41e-05	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—hematologic cancer	1.34e-05	6.4e-05	CcSEcCtD
Morphine—Vertigo—Methotrexate—hematologic cancer	1.33e-05	6.39e-05	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.33e-05	6.37e-05	CcSEcCtD
Morphine—Leukopenia—Methotrexate—hematologic cancer	1.33e-05	6.36e-05	CcSEcCtD
Morphine—Chills—Doxorubicin—hematologic cancer	1.33e-05	6.35e-05	CcSEcCtD
Morphine—Urticaria—Betamethasone—hematologic cancer	1.32e-05	6.33e-05	CcSEcCtD
Morphine—Urticaria—Dexamethasone—hematologic cancer	1.32e-05	6.33e-05	CcSEcCtD
Morphine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.32e-05	6.33e-05	CcSEcCtD
Morphine—Dizziness—Prednisolone—hematologic cancer	1.32e-05	6.32e-05	CcSEcCtD
Morphine—Asthenia—Triamcinolone—hematologic cancer	1.32e-05	6.3e-05	CcSEcCtD
Morphine—Abdominal pain—Betamethasone—hematologic cancer	1.32e-05	6.3e-05	CcSEcCtD
Morphine—Abdominal pain—Dexamethasone—hematologic cancer	1.32e-05	6.3e-05	CcSEcCtD
Morphine—Body temperature increased—Dexamethasone—hematologic cancer	1.32e-05	6.3e-05	CcSEcCtD
Morphine—Body temperature increased—Betamethasone—hematologic cancer	1.32e-05	6.3e-05	CcSEcCtD
Morphine—Nausea—Cisplatin—hematologic cancer	1.31e-05	6.28e-05	CcSEcCtD
Morphine—Insomnia—Prednisone—hematologic cancer	1.31e-05	6.28e-05	CcSEcCtD
Morphine—Vision blurred—Epirubicin—hematologic cancer	1.31e-05	6.27e-05	CcSEcCtD
Morphine—Paraesthesia—Prednisone—hematologic cancer	1.3e-05	6.23e-05	CcSEcCtD
Morphine—Pruritus—Triamcinolone—hematologic cancer	1.3e-05	6.22e-05	CcSEcCtD
Morphine—Cough—Methotrexate—hematologic cancer	1.3e-05	6.2e-05	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—hematologic cancer	1.29e-05	6.2e-05	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—hematologic cancer	1.29e-05	6.17e-05	CcSEcCtD
Morphine—Convulsion—Methotrexate—hematologic cancer	1.29e-05	6.16e-05	CcSEcCtD
Morphine—Vomiting—Etoposide—hematologic cancer	1.29e-05	6.16e-05	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—hematologic cancer	1.29e-05	6.16e-05	CcSEcCtD
Morphine—Erythema—Doxorubicin—hematologic cancer	1.29e-05	6.16e-05	CcSEcCtD
Morphine—Anaemia—Epirubicin—hematologic cancer	1.28e-05	6.15e-05	CcSEcCtD
Morphine—Agitation—Epirubicin—hematologic cancer	1.28e-05	6.11e-05	CcSEcCtD
Morphine—Dyspepsia—Prednisone—hematologic cancer	1.28e-05	6.11e-05	CcSEcCtD
Morphine—Rash—Etoposide—hematologic cancer	1.28e-05	6.11e-05	CcSEcCtD
Morphine—Dermatitis—Etoposide—hematologic cancer	1.27e-05	6.1e-05	CcSEcCtD
Morphine—Headache—Etoposide—hematologic cancer	1.27e-05	6.07e-05	CcSEcCtD
Morphine—Flatulence—Doxorubicin—hematologic cancer	1.27e-05	6.07e-05	CcSEcCtD
Morphine—Arthralgia—Methotrexate—hematologic cancer	1.26e-05	6.05e-05	CcSEcCtD
Morphine—Chest pain—Methotrexate—hematologic cancer	1.26e-05	6.05e-05	CcSEcCtD
Morphine—Tension—Doxorubicin—hematologic cancer	1.26e-05	6.04e-05	CcSEcCtD
Morphine—Decreased appetite—Prednisone—hematologic cancer	1.26e-05	6.04e-05	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—hematologic cancer	1.26e-05	6.03e-05	CcSEcCtD
Morphine—Rash—Prednisolone—hematologic cancer	1.26e-05	6.02e-05	CcSEcCtD
Morphine—Dermatitis—Prednisolone—hematologic cancer	1.26e-05	6.02e-05	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.26e-05	6.01e-05	CcSEcCtD
Morphine—Malaise—Epirubicin—hematologic cancer	1.25e-05	6e-05	CcSEcCtD
Morphine—Fatigue—Prednisone—hematologic cancer	1.25e-05	5.99e-05	CcSEcCtD
Morphine—Headache—Prednisolone—hematologic cancer	1.25e-05	5.99e-05	CcSEcCtD
Morphine—Discomfort—Methotrexate—hematologic cancer	1.25e-05	5.98e-05	CcSEcCtD
Morphine—Nervousness—Doxorubicin—hematologic cancer	1.25e-05	5.98e-05	CcSEcCtD
Morphine—Vertigo—Epirubicin—hematologic cancer	1.25e-05	5.98e-05	CcSEcCtD
Morphine—Syncope—Epirubicin—hematologic cancer	1.25e-05	5.97e-05	CcSEcCtD
Morphine—Leukopenia—Epirubicin—hematologic cancer	1.24e-05	5.96e-05	CcSEcCtD
Morphine—Back pain—Doxorubicin—hematologic cancer	1.24e-05	5.95e-05	CcSEcCtD
Morphine—Constipation—Prednisone—hematologic cancer	1.24e-05	5.94e-05	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—hematologic cancer	1.24e-05	5.92e-05	CcSEcCtD
Morphine—Palpitations—Epirubicin—hematologic cancer	1.23e-05	5.88e-05	CcSEcCtD
Morphine—Confusional state—Methotrexate—hematologic cancer	1.22e-05	5.85e-05	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—hematologic cancer	1.22e-05	5.85e-05	CcSEcCtD
Morphine—Dizziness—Triamcinolone—hematologic cancer	1.21e-05	5.81e-05	CcSEcCtD
Morphine—Cough—Epirubicin—hematologic cancer	1.21e-05	5.81e-05	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—hematologic cancer	1.21e-05	5.8e-05	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—hematologic cancer	1.21e-05	5.8e-05	CcSEcCtD
Morphine—Convulsion—Epirubicin—hematologic cancer	1.2e-05	5.76e-05	CcSEcCtD
Morphine—Infection—Methotrexate—hematologic cancer	1.2e-05	5.76e-05	CcSEcCtD
Morphine—Nausea—Etoposide—hematologic cancer	1.2e-05	5.75e-05	CcSEcCtD
Morphine—Hypertension—Epirubicin—hematologic cancer	1.2e-05	5.74e-05	CcSEcCtD
Morphine—Feeling abnormal—Prednisone—hematologic cancer	1.19e-05	5.72e-05	CcSEcCtD
Morphine—Asthenia—Betamethasone—hematologic cancer	1.19e-05	5.72e-05	CcSEcCtD
Morphine—Asthenia—Dexamethasone—hematologic cancer	1.19e-05	5.72e-05	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.19e-05	5.71e-05	CcSEcCtD
Morphine—Nervous system disorder—Methotrexate—hematologic cancer	1.19e-05	5.69e-05	CcSEcCtD
Morphine—Anaemia—Doxorubicin—hematologic cancer	1.19e-05	5.69e-05	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—hematologic cancer	1.19e-05	5.68e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Prednisone—hematologic cancer	1.19e-05	5.68e-05	CcSEcCtD
Morphine—Nausea—Prednisolone—hematologic cancer	1.19e-05	5.68e-05	CcSEcCtD
Morphine—Chest pain—Epirubicin—hematologic cancer	1.18e-05	5.66e-05	CcSEcCtD
Morphine—Arthralgia—Epirubicin—hematologic cancer	1.18e-05	5.66e-05	CcSEcCtD
Morphine—Agitation—Doxorubicin—hematologic cancer	1.18e-05	5.66e-05	CcSEcCtD
Morphine—Anxiety—Epirubicin—hematologic cancer	1.18e-05	5.64e-05	CcSEcCtD
Morphine—Pruritus—Dexamethasone—hematologic cancer	1.18e-05	5.64e-05	CcSEcCtD
Morphine—Pruritus—Betamethasone—hematologic cancer	1.18e-05	5.64e-05	CcSEcCtD
Morphine—Skin disorder—Methotrexate—hematologic cancer	1.18e-05	5.64e-05	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.17e-05	5.63e-05	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—hematologic cancer	1.17e-05	5.61e-05	CcSEcCtD
Morphine—Discomfort—Epirubicin—hematologic cancer	1.17e-05	5.6e-05	CcSEcCtD
Morphine—Vomiting—Triamcinolone—hematologic cancer	1.17e-05	5.59e-05	CcSEcCtD
Morphine—Malaise—Doxorubicin—hematologic cancer	1.16e-05	5.55e-05	CcSEcCtD
Morphine—Rash—Triamcinolone—hematologic cancer	1.16e-05	5.54e-05	CcSEcCtD
Morphine—Dry mouth—Epirubicin—hematologic cancer	1.16e-05	5.54e-05	CcSEcCtD
Morphine—Dermatitis—Triamcinolone—hematologic cancer	1.16e-05	5.53e-05	CcSEcCtD
Morphine—Vertigo—Doxorubicin—hematologic cancer	1.16e-05	5.53e-05	CcSEcCtD
Morphine—Anorexia—Methotrexate—hematologic cancer	1.15e-05	5.53e-05	CcSEcCtD
Morphine—Syncope—Doxorubicin—hematologic cancer	1.15e-05	5.52e-05	CcSEcCtD
Morphine—Urticaria—Prednisone—hematologic cancer	1.15e-05	5.52e-05	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—hematologic cancer	1.15e-05	5.51e-05	CcSEcCtD
Morphine—Headache—Triamcinolone—hematologic cancer	1.15e-05	5.5e-05	CcSEcCtD
Morphine—Abdominal pain—Prednisone—hematologic cancer	1.15e-05	5.49e-05	CcSEcCtD
Morphine—Body temperature increased—Prednisone—hematologic cancer	1.15e-05	5.49e-05	CcSEcCtD
Morphine—Confusional state—Epirubicin—hematologic cancer	1.14e-05	5.48e-05	CcSEcCtD
Morphine—Diarrhoea—Dexamethasone—hematologic cancer	1.14e-05	5.45e-05	CcSEcCtD
Morphine—Diarrhoea—Betamethasone—hematologic cancer	1.14e-05	5.45e-05	CcSEcCtD
Morphine—Palpitations—Doxorubicin—hematologic cancer	1.14e-05	5.44e-05	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—hematologic cancer	1.13e-05	5.43e-05	CcSEcCtD
Morphine—Oedema—Epirubicin—hematologic cancer	1.13e-05	5.43e-05	CcSEcCtD
Morphine—Hypotension—Methotrexate—hematologic cancer	1.13e-05	5.42e-05	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—hematologic cancer	1.13e-05	5.41e-05	CcSEcCtD
Morphine—Infection—Epirubicin—hematologic cancer	1.13e-05	5.39e-05	CcSEcCtD
Morphine—Cough—Doxorubicin—hematologic cancer	1.12e-05	5.37e-05	CcSEcCtD
Morphine—Shock—Epirubicin—hematologic cancer	1.12e-05	5.34e-05	CcSEcCtD
Morphine—Convulsion—Doxorubicin—hematologic cancer	1.11e-05	5.33e-05	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—hematologic cancer	1.11e-05	5.33e-05	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—hematologic cancer	1.11e-05	5.32e-05	CcSEcCtD
Morphine—Hypertension—Doxorubicin—hematologic cancer	1.11e-05	5.32e-05	CcSEcCtD
Morphine—Tachycardia—Epirubicin—hematologic cancer	1.11e-05	5.3e-05	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.1e-05	5.29e-05	CcSEcCtD
Morphine—Skin disorder—Epirubicin—hematologic cancer	1.1e-05	5.27e-05	CcSEcCtD
Morphine—Dizziness—Dexamethasone—hematologic cancer	1.1e-05	5.27e-05	CcSEcCtD
Morphine—Dizziness—Betamethasone—hematologic cancer	1.1e-05	5.27e-05	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—hematologic cancer	1.1e-05	5.25e-05	CcSEcCtD
Morphine—Insomnia—Methotrexate—hematologic cancer	1.1e-05	5.25e-05	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—hematologic cancer	1.09e-05	5.24e-05	CcSEcCtD
Morphine—Chest pain—Doxorubicin—hematologic cancer	1.09e-05	5.24e-05	CcSEcCtD
Morphine—Anxiety—Doxorubicin—hematologic cancer	1.09e-05	5.22e-05	CcSEcCtD
Morphine—Nausea—Triamcinolone—hematologic cancer	1.09e-05	5.22e-05	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—hematologic cancer	1.09e-05	5.21e-05	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.09e-05	5.21e-05	CcSEcCtD
Morphine—Discomfort—Doxorubicin—hematologic cancer	1.08e-05	5.18e-05	CcSEcCtD
Morphine—Anorexia—Epirubicin—hematologic cancer	1.08e-05	5.18e-05	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—hematologic cancer	1.08e-05	5.17e-05	CcSEcCtD
Morphine—Somnolence—Methotrexate—hematologic cancer	1.08e-05	5.16e-05	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—hematologic cancer	1.07e-05	5.13e-05	CcSEcCtD
Morphine—Hypersensitivity—Prednisone—hematologic cancer	1.07e-05	5.12e-05	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—hematologic cancer	1.07e-05	5.11e-05	CcSEcCtD
Morphine—Hypotension—Epirubicin—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Morphine—Vomiting—Dexamethasone—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Morphine—Vomiting—Betamethasone—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Morphine—Confusional state—Doxorubicin—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—hematologic cancer	1.05e-05	5.04e-05	CcSEcCtD
Morphine—Rash—Dexamethasone—hematologic cancer	1.05e-05	5.03e-05	CcSEcCtD
Morphine—Rash—Betamethasone—hematologic cancer	1.05e-05	5.03e-05	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.05e-05	5.02e-05	CcSEcCtD
Morphine—Oedema—Doxorubicin—hematologic cancer	1.05e-05	5.02e-05	CcSEcCtD
Morphine—Dermatitis—Betamethasone—hematologic cancer	1.05e-05	5.02e-05	CcSEcCtD
Morphine—Dermatitis—Dexamethasone—hematologic cancer	1.05e-05	5.02e-05	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.05e-05	5.01e-05	CcSEcCtD
Morphine—Fatigue—Methotrexate—hematologic cancer	1.04e-05	5e-05	CcSEcCtD
Morphine—Headache—Dexamethasone—hematologic cancer	1.04e-05	4.99e-05	CcSEcCtD
Morphine—Headache—Betamethasone—hematologic cancer	1.04e-05	4.99e-05	CcSEcCtD
Morphine—Infection—Doxorubicin—hematologic cancer	1.04e-05	4.99e-05	CcSEcCtD
Morphine—Asthenia—Prednisone—hematologic cancer	1.04e-05	4.98e-05	CcSEcCtD
Morphine—Pain—Methotrexate—hematologic cancer	1.04e-05	4.96e-05	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.03e-05	4.95e-05	CcSEcCtD
Morphine—Shock—Doxorubicin—hematologic cancer	1.03e-05	4.94e-05	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—hematologic cancer	1.03e-05	4.93e-05	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.03e-05	4.92e-05	CcSEcCtD
Morphine—Pruritus—Prednisone—hematologic cancer	1.03e-05	4.91e-05	CcSEcCtD
Morphine—Insomnia—Epirubicin—hematologic cancer	1.03e-05	4.91e-05	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—hematologic cancer	1.02e-05	4.9e-05	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—hematologic cancer	1.02e-05	4.88e-05	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—hematologic cancer	1.02e-05	4.88e-05	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.01e-05	4.86e-05	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—hematologic cancer	1.01e-05	4.84e-05	CcSEcCtD
Morphine—Somnolence—Epirubicin—hematologic cancer	1.01e-05	4.83e-05	CcSEcCtD
Morphine—Anorexia—Doxorubicin—hematologic cancer	1e-05	4.79e-05	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—hematologic cancer	9.98e-06	4.78e-05	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—hematologic cancer	9.98e-06	4.78e-05	CcSEcCtD
Morphine—Diarrhoea—Prednisone—hematologic cancer	9.92e-06	4.75e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Methotrexate—hematologic cancer	9.91e-06	4.74e-05	CcSEcCtD
Morphine—Nausea—Betamethasone—hematologic cancer	9.89e-06	4.74e-05	CcSEcCtD
Morphine—Nausea—Dexamethasone—hematologic cancer	9.89e-06	4.74e-05	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—hematologic cancer	9.86e-06	4.72e-05	CcSEcCtD
Morphine—Hypotension—Doxorubicin—hematologic cancer	9.8e-06	4.69e-05	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.79e-06	4.69e-05	CcSEcCtD
Morphine—Fatigue—Epirubicin—hematologic cancer	9.78e-06	4.68e-05	CcSEcCtD
Morphine—Pain—Epirubicin—hematologic cancer	9.7e-06	4.64e-05	CcSEcCtD
Morphine—Constipation—Epirubicin—hematologic cancer	9.7e-06	4.64e-05	CcSEcCtD
Morphine—Urticaria—Methotrexate—hematologic cancer	9.63e-06	4.61e-05	CcSEcCtD
Morphine—Dizziness—Prednisone—hematologic cancer	9.59e-06	4.59e-05	CcSEcCtD
Morphine—Abdominal pain—Methotrexate—hematologic cancer	9.58e-06	4.59e-05	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—hematologic cancer	9.58e-06	4.59e-05	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.56e-06	4.58e-05	CcSEcCtD
Morphine—Insomnia—Doxorubicin—hematologic cancer	9.49e-06	4.54e-05	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—hematologic cancer	9.42e-06	4.51e-05	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—hematologic cancer	9.35e-06	4.48e-05	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—hematologic cancer	9.34e-06	4.47e-05	CcSEcCtD
Morphine—Somnolence—Doxorubicin—hematologic cancer	9.33e-06	4.47e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—hematologic cancer	9.27e-06	4.44e-05	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—hematologic cancer	9.24e-06	4.42e-05	CcSEcCtD
Morphine—Vomiting—Prednisone—hematologic cancer	9.22e-06	4.41e-05	CcSEcCtD
Morphine—Rash—Prednisone—hematologic cancer	9.14e-06	4.38e-05	CcSEcCtD
Morphine—Dermatitis—Prednisone—hematologic cancer	9.13e-06	4.37e-05	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—hematologic cancer	9.12e-06	4.37e-05	CcSEcCtD
Morphine—Headache—Prednisone—hematologic cancer	9.08e-06	4.35e-05	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.06e-06	4.34e-05	CcSEcCtD
Morphine—Fatigue—Doxorubicin—hematologic cancer	9.05e-06	4.33e-05	CcSEcCtD
Morphine—Urticaria—Epirubicin—hematologic cancer	9.01e-06	4.31e-05	CcSEcCtD
Morphine—Pain—Doxorubicin—hematologic cancer	8.97e-06	4.3e-05	CcSEcCtD
Morphine—Constipation—Doxorubicin—hematologic cancer	8.97e-06	4.3e-05	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—hematologic cancer	8.96e-06	4.29e-05	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—hematologic cancer	8.96e-06	4.29e-05	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—hematologic cancer	8.93e-06	4.27e-05	CcSEcCtD
Morphine—Asthenia—Methotrexate—hematologic cancer	8.69e-06	4.16e-05	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—hematologic cancer	8.65e-06	4.14e-05	CcSEcCtD
Morphine—Nausea—Prednisone—hematologic cancer	8.61e-06	4.12e-05	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.58e-06	4.11e-05	CcSEcCtD
Morphine—Pruritus—Methotrexate—hematologic cancer	8.57e-06	4.11e-05	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—hematologic cancer	8.35e-06	4e-05	CcSEcCtD
Morphine—Urticaria—Doxorubicin—hematologic cancer	8.33e-06	3.99e-05	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—hematologic cancer	8.29e-06	3.97e-05	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—hematologic cancer	8.29e-06	3.97e-05	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—hematologic cancer	8.29e-06	3.97e-05	CcSEcCtD
Morphine—Asthenia—Epirubicin—hematologic cancer	8.14e-06	3.9e-05	CcSEcCtD
Morphine—Pruritus—Epirubicin—hematologic cancer	8.02e-06	3.84e-05	CcSEcCtD
Morphine—Dizziness—Methotrexate—hematologic cancer	8.01e-06	3.84e-05	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—hematologic cancer	7.76e-06	3.72e-05	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—hematologic cancer	7.73e-06	3.7e-05	CcSEcCtD
Morphine—Vomiting—Methotrexate—hematologic cancer	7.7e-06	3.69e-05	CcSEcCtD
Morphine—Rash—Methotrexate—hematologic cancer	7.64e-06	3.66e-05	CcSEcCtD
Morphine—Dermatitis—Methotrexate—hematologic cancer	7.63e-06	3.66e-05	CcSEcCtD
Morphine—Headache—Methotrexate—hematologic cancer	7.59e-06	3.64e-05	CcSEcCtD
Morphine—Asthenia—Doxorubicin—hematologic cancer	7.53e-06	3.6e-05	CcSEcCtD
Morphine—Dizziness—Epirubicin—hematologic cancer	7.5e-06	3.59e-05	CcSEcCtD
Morphine—Pruritus—Doxorubicin—hematologic cancer	7.42e-06	3.55e-05	CcSEcCtD
Morphine—Vomiting—Epirubicin—hematologic cancer	7.21e-06	3.45e-05	CcSEcCtD
Morphine—Nausea—Methotrexate—hematologic cancer	7.2e-06	3.45e-05	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—hematologic cancer	7.18e-06	3.44e-05	CcSEcCtD
Morphine—Rash—Epirubicin—hematologic cancer	7.15e-06	3.42e-05	CcSEcCtD
Morphine—Dermatitis—Epirubicin—hematologic cancer	7.14e-06	3.42e-05	CcSEcCtD
Morphine—Headache—Epirubicin—hematologic cancer	7.1e-06	3.4e-05	CcSEcCtD
Morphine—Dizziness—Doxorubicin—hematologic cancer	6.94e-06	3.32e-05	CcSEcCtD
Morphine—Nausea—Epirubicin—hematologic cancer	6.74e-06	3.23e-05	CcSEcCtD
Morphine—Vomiting—Doxorubicin—hematologic cancer	6.67e-06	3.19e-05	CcSEcCtD
Morphine—Rash—Doxorubicin—hematologic cancer	6.62e-06	3.17e-05	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—hematologic cancer	6.61e-06	3.17e-05	CcSEcCtD
Morphine—Headache—Doxorubicin—hematologic cancer	6.57e-06	3.15e-05	CcSEcCtD
Morphine—Nausea—Doxorubicin—hematologic cancer	6.23e-06	2.98e-05	CcSEcCtD
Morphine—CYP2C8—Metabolism—NQO1—hematologic cancer	3.32e-06	3.9e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CREB1—hematologic cancer	3.31e-06	3.88e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	3.29e-06	3.86e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.28e-06	3.85e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—EP300—hematologic cancer	3.28e-06	3.85e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—BRAF—hematologic cancer	3.27e-06	3.83e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.26e-06	3.83e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.26e-06	3.82e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.26e-06	3.82e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.26e-06	3.82e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL2—hematologic cancer	3.24e-06	3.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6R—hematologic cancer	3.23e-06	3.79e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	3.22e-06	3.78e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SDC1—hematologic cancer	3.21e-06	3.76e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	3.2e-06	3.75e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—JAK2—hematologic cancer	3.2e-06	3.75e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	3.17e-06	3.72e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CD—hematologic cancer	3.16e-06	3.7e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYCS—hematologic cancer	3.15e-06	3.69e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	3.13e-06	3.68e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.13e-06	3.67e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MDM2—hematologic cancer	3.12e-06	3.66e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—hematologic cancer	3.12e-06	3.66e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ESR1—hematologic cancer	3.11e-06	3.65e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	3.08e-06	3.61e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FN1—hematologic cancer	3.07e-06	3.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.06e-06	3.59e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	3.06e-06	3.58e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.05e-06	3.58e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	3.04e-06	3.56e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MTOR—hematologic cancer	3.04e-06	3.56e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BAD—hematologic cancer	3.03e-06	3.56e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	3.03e-06	3.56e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.03e-06	3.55e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	3e-06	3.52e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	2.99e-06	3.51e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3R1—hematologic cancer	2.98e-06	3.5e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CA9—hematologic cancer	2.98e-06	3.49e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ACP5—hematologic cancer	2.98e-06	3.49e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CD80—hematologic cancer	2.94e-06	3.45e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.94e-06	3.45e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	2.94e-06	3.45e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KIT—hematologic cancer	2.94e-06	3.45e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	2.94e-06	3.45e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—hematologic cancer	2.93e-06	3.43e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGF2—hematologic cancer	2.93e-06	3.43e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	2.9e-06	3.4e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NQO1—hematologic cancer	2.9e-06	3.4e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CD44—hematologic cancer	2.9e-06	3.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	2.89e-06	3.39e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	2.89e-06	3.38e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	2.85e-06	3.34e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	2.82e-06	3.31e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	2.81e-06	3.3e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.81e-06	3.3e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JAK2—hematologic cancer	2.8e-06	3.29e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—IDH1—hematologic cancer	2.8e-06	3.28e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CREB1—hematologic cancer	2.8e-06	3.28e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—hematologic cancer	2.79e-06	3.28e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—EP300—hematologic cancer	2.79e-06	3.27e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—hematologic cancer	2.79e-06	3.27e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—hematologic cancer	2.78e-06	3.26e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.77e-06	3.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.77e-06	3.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.77e-06	3.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TXN—hematologic cancer	2.77e-06	3.25e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—BRAF—hematologic cancer	2.76e-06	3.24e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CB—hematologic cancer	2.75e-06	3.23e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	2.75e-06	3.22e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYCS—hematologic cancer	2.74e-06	3.21e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MDM2—hematologic cancer	2.74e-06	3.21e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL2—hematologic cancer	2.74e-06	3.21e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CD44—hematologic cancer	2.73e-06	3.2e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NQO1—hematologic cancer	2.73e-06	3.2e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6R—hematologic cancer	2.73e-06	3.2e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	2.72e-06	3.19e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.72e-06	3.19e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—hematologic cancer	2.72e-06	3.19e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—JUN—hematologic cancer	2.71e-06	3.18e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.71e-06	3.18e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.68e-06	3.15e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MTOR—hematologic cancer	2.66e-06	3.12e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	2.66e-06	3.12e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	2.63e-06	3.09e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—hematologic cancer	2.62e-06	3.08e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.62e-06	3.08e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.6e-06	3.05e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.6e-06	3.05e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.58e-06	3.03e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYCS—hematologic cancer	2.58e-06	3.03e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	2.57e-06	3.01e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.57e-06	3.01e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	2.56e-06	3e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.56e-06	3e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.55e-06	2.99e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.55e-06	2.99e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	2.54e-06	2.98e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.53e-06	2.97e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.53e-06	2.97e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	2.53e-06	2.97e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EP300—hematologic cancer	2.5e-06	2.94e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	2.5e-06	2.93e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGF2—hematologic cancer	2.47e-06	2.9e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	2.47e-06	2.9e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.47e-06	2.89e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—hematologic cancer	2.45e-06	2.87e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—hematologic cancer	2.45e-06	2.87e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.44e-06	2.86e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SRC—hematologic cancer	2.43e-06	2.86e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—hematologic cancer	2.43e-06	2.85e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—hematologic cancer	2.43e-06	2.85e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—hematologic cancer	2.42e-06	2.83e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.39e-06	2.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—hematologic cancer	2.38e-06	2.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JUN—hematologic cancer	2.38e-06	2.79e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—hematologic cancer	2.38e-06	2.79e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	2.37e-06	2.78e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JAK2—hematologic cancer	2.37e-06	2.78e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—hematologic cancer	2.35e-06	2.75e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—hematologic cancer	2.34e-06	2.75e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.32e-06	2.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.32e-06	2.72e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.32e-06	2.72e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MDM2—hematologic cancer	2.31e-06	2.71e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	2.31e-06	2.71e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.3e-06	2.7e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—hematologic cancer	2.3e-06	2.7e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.28e-06	2.67e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—EP300—hematologic cancer	2.27e-06	2.66e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTR—hematologic cancer	2.26e-06	2.65e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.26e-06	2.65e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.25e-06	2.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	2.25e-06	2.64e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MTOR—hematologic cancer	2.25e-06	2.64e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	2.25e-06	2.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	2.25e-06	2.63e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	2.24e-06	2.63e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.22e-06	2.6e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.22e-06	2.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.21e-06	2.6e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EP300—hematologic cancer	2.19e-06	2.57e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—hematologic cancer	2.18e-06	2.56e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	2.18e-06	2.55e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.15e-06	2.53e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	2.15e-06	2.52e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.15e-06	2.52e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SRC—hematologic cancer	2.13e-06	2.5e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	2.11e-06	2.48e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.1e-06	2.46e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.09e-06	2.45e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.09e-06	2.45e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	2.09e-06	2.45e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	2.08e-06	2.44e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—hematologic cancer	2.07e-06	2.43e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—hematologic cancer	2.07e-06	2.42e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—hematologic cancer	2.07e-06	2.42e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—hematologic cancer	2.06e-06	2.41e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—hematologic cancer	2.06e-06	2.41e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—hematologic cancer	2.05e-06	2.41e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—hematologic cancer	2.02e-06	2.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—hematologic cancer	2.02e-06	2.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JUN—hematologic cancer	2.01e-06	2.36e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.98e-06	2.33e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—hematologic cancer	1.98e-06	2.33e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	1.97e-06	2.31e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—hematologic cancer	1.96e-06	2.3e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.95e-06	2.29e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—hematologic cancer	1.95e-06	2.28e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—hematologic cancer	1.91e-06	2.24e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	1.91e-06	2.24e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	1.9e-06	2.23e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	1.9e-06	2.23e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.89e-06	2.22e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EP300—hematologic cancer	1.86e-06	2.18e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	1.85e-06	2.17e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.85e-06	2.17e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SRC—hematologic cancer	1.8e-06	2.12e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—hematologic cancer	1.79e-06	2.1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CD44—hematologic cancer	1.78e-06	2.09e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.78e-06	2.09e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—hematologic cancer	1.77e-06	2.07e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	1.76e-06	2.06e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.75e-06	2.06e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—hematologic cancer	1.74e-06	2.04e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—hematologic cancer	1.74e-06	2.04e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—hematologic cancer	1.71e-06	2.01e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.69e-06	1.98e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—hematologic cancer	1.69e-06	1.98e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—hematologic cancer	1.68e-06	1.97e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.68e-06	1.97e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.66e-06	1.95e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	1.66e-06	1.95e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.65e-06	1.93e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—hematologic cancer	1.64e-06	1.93e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—hematologic cancer	1.64e-06	1.92e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	1.62e-06	1.9e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—hematologic cancer	1.62e-06	1.9e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	1.61e-06	1.89e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—hematologic cancer	1.57e-06	1.84e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.57e-06	1.84e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.55e-06	1.82e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.53e-06	1.79e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—hematologic cancer	1.51e-06	1.77e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.5e-06	1.76e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—hematologic cancer	1.49e-06	1.75e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.49e-06	1.75e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.45e-06	1.7e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.45e-06	1.7e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.44e-06	1.69e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.44e-06	1.69e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—hematologic cancer	1.43e-06	1.68e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.41e-06	1.65e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—hematologic cancer	1.37e-06	1.61e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.37e-06	1.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.37e-06	1.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.37e-06	1.6e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.37e-06	1.6e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—hematologic cancer	1.35e-06	1.58e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.33e-06	1.56e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.33e-06	1.56e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.29e-06	1.51e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.27e-06	1.49e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.26e-06	1.48e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.25e-06	1.47e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.22e-06	1.43e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.21e-06	1.42e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—EP300—hematologic cancer	1.19e-06	1.4e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.19e-06	1.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.12e-06	1.31e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—hematologic cancer	1.09e-06	1.28e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—EP300—hematologic cancer	1.04e-06	1.22e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.03e-06	1.21e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.02e-06	1.19e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—EP300—hematologic cancer	9.81e-07	1.15e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.41e-07	1.1e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.93e-07	1.05e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	8.84e-07	1.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—hematologic cancer	8.81e-07	1.03e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.43e-07	9.89e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.78e-07	9.13e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.7e-07	9.03e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.25e-07	8.51e-06	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—hematologic cancer	7.22e-07	8.47e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—hematologic cancer	6.72e-07	7.89e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—EP300—hematologic cancer	6.41e-07	7.52e-06	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—hematologic cancer	6.29e-07	7.38e-06	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—hematologic cancer	5.93e-07	6.95e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.74e-07	5.56e-06	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—hematologic cancer	3.87e-07	4.55e-06	CbGpPWpGaD
